trending Market Intelligence /marketintelligence/en/news-insights/trending/75q3cikf25kuiz3yp8kjiw2 content esgSubNav
In This List

Intec Pharma appoints director

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise

Blog

Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises


Intec Pharma appoints director

Intec Pharma Ltd. appointed Roger Pomerantz as a director.

Pomerantz's appointment brings the number of Intec's board members to seven, six of whom are independent. Pomerantz is the president, CEO and board chairman of Seres Therapeutics Inc.

Jerusalem, Israel-based Intec Pharma is a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology. The Accordion Pill is an oral drug delivery system designed to improve the efficacy and safety of existing drugs and drugs in development by utilizing a gastric retention and specific release mechanism.